DIGITAL EDITIONS

Category: Topical treatments

Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris

April 1, 2020

J Clin Aesthet Dermatol. 2020;13(4):14–21 by Leon Kircik, MD; James Q Del Rosso, DO; Jonathan S Weiss, MD; Vassilis Stakias, PharmD; Anat London, PhD; Rita Keynan; Yohan Hazot; Russell Elliott, PhD; and Iain Stuart, PhD Dr. Kircik is with the Icahn School of Medicine at Mount Sinai in New York, New York. Dr. Del Rosso

Examining 15% Azelaic Acid Foam for the Treatment of Folliculitis: A Pilot Study

April 1, 2020

J Clin Aesthet Dermatol. 2020;13(4):36–38 by Zoe Diana Draelos, MD Dr. Draelos is with Dermatology Consulting Services, PLLC in High Point, North Carolina. FUNDING: Funding was provided by Leo Pharma. DISCLOSURES: The authors have no conflicts of interest relevant to the content of this article. ABSTRACT: Background. Folliculitis is a frequently recurrent skin condition characterized

Efficacy of Topical Timolol 0.5% in the Treatment of Acne and Rosacea: A Multicentric Study

March 1, 2020

Background. Acne and rosacea are common chronic inflammatory skin diseases associated with psychosocial impairment, anxiety, depression, and impaired overall quality of life.

Topical Corticosteroid Therapy for Psoriasis—A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification

February 1, 2020

J Clin Aesthet Dermatol. 2020;13(2):22–29 by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada and Touro University Nevada in Henderson, Nevada. FUNDING: No funding was provided for this review. DISCLOSURES: Dr. Del Rosso has served as a consultant, speaker, and research investigator for

Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study

February 1, 2020

Background. Vitiligo is an acquired disorder characterized by depigmented macules or patches on the skin due to the loss of functional melanocytes. Segmental vitiligo (SV) is a subtype of vitiligo refractory to treatment.